Business Context and Reporting Period
Company: Recursion Pharmaceuticals, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: June 13, 2023
Event: Regulation FD Disclosure regarding the release of an updated investor presentation.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves solely to disclose the availability of an updated investor presentation (Exhibit 99.1) and does not contain a financial statement or earnings release.
Material Changes
No material financial changes or operational updates are detailed within the text of this Form 8-K. The document references an attached investor presentation for further details but does not summarize those contents.
Guidance, Outlook, and Risks
Management Commentary: The company released an updated investor presentation for use in meetings with investors.
Legal Disclaimer: The information furnished in this Item 7.01 and the attached Exhibit 99.1 is not deemed "filed" under Section 18 of the Securities Exchange Act of 1934 and is not subject to the liabilities of that section. It is not incorporated by reference into other filings unless expressly stated.
Investor Verification Checklist
- Review the attached Exhibit 99.1 (Investor Presentation dated June 13, 2023) for specific financial data and strategic updates.
- Verify that the presentation is not incorporated by reference into other SEC filings unless explicitly noted.
- Check subsequent filings (e.g., 10-Q or 10-K) for audited or reviewed financial metrics not present in this 8-K.